This tax information and impact note applies to companies that carry out R&D into prescribed types of vaccine and other medicine.
This measure provides for the expiry of vaccine research relief, in respect of expenditure incurred on or after 1 April 2017.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.